A comprehensive macrophage-T-lymphocyte theory of schizophrenia
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ban, 1972, 3
Johnstone, 1991, The nature and management of schizophrenia, Scott Medical J, 36, 4, 10.1177/003693309103600102
Davis, 1991, Dopamine in schizophrenia: A review and reconceptualization, Am J Psychiatry, 148, 1474, 10.1176/ajp.148.11.1474
Baldessarini, 1991, Clozapine: A novel antipsychotic agent, N Engl J Med, 324, 746, 10.1056/NEJM199103143241107
Widerlov, 1988, A critical appraisal of CSF monoamine metabolite studies in schizophrenia, Ann NY Acad Sci, 537, 309, 10.1111/j.1749-6632.1988.tb42115.x
Moises, 1990, No linkage between D2 dopamine receptor gene region and schizophrenia, Arch Gen Psychiatry, 48, 643, 10.1001/archpsyc.1991.01810310061011
Freed, 1988, The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensitivity, Schizophrenia Bull, 14, 269, 10.1093/schbul/14.2.269
Hollister, 1987, Novel drug treatments for schizophrenia, Psychopharmacol Bull, 23, 82
Smith, 1991, Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 by gastrointestinal lymphocytes?, Medical Hypoth, 34, 225, 10.1016/0306-9877(91)90215-K
Smith, 1992, The GI T-lymphocyte theory of schizophrenia: some new observations, Medical Hypoth, 37, 27, 10.1016/0306-9877(92)90008-Z
Denicoff, 1987, The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells, Ann Internal Med, 107, 293, 10.7326/0003-4819-107-2-293
Ovadia, 1987, Dopamine receptors on isolated membranes of rat lymphocytes, J Neurosci Res, 18, 70, 10.1002/jnr.490180112
Boukhris, 1988, Differential effect of mixed D1D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro, Immunopharmacol Immunotoxicol, 10, 501, 10.3109/08923978809006451
Schleuning, 1989, Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes, Eur J Immunol, 19, 1491, 10.1002/eji.1830190822
Black, 1988, Schizophrenia, schizophreniform disorder, and delusional (paranoid) disorders, 357
Grodzicki, 1990, Differences in [3H]-spiperone binding to peripheral blood lymphocytes from neuroleptic responsive and non responsive schizophrenic patients, Biol Psychiatry, 27, 1327, 10.1016/0006-3223(90)90503-T
Shepherd, 1988, Neurobiology, 499
De Sarro, 1990, Behavioral and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone, Neuropharmacol, 29, 167, 10.1016/0028-3908(90)90057-X
Rasmussen, 1988, Potency of antipsychotics in reversing effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity, Neuropsychopharmacology, 1, 101, 10.1016/0893-133X(88)90001-2
De Sarro, 1987, Evidence that locus coeruleus is the site where clonidine and drugs acting at a-1 and a-2 adrenoceptors affect sleep and arousal mechanisms, Br J Pharmacol, 90, 675, 10.1111/j.1476-5381.1987.tb11220.x
De Sarro, 1988, Behavioural and ECoG spectrum power effects induced bymicroinfusion of compounds acting at different opiod receptors into the locus coeruleus, Neurosci Lett, 33, 74S
Nistico, 1991, Is interleukin 2 a neuromodulator in the brain?, TINS, 14, 146
Van Kammen, 1987, Biochemical instability in schizophrenia 1: The norepinephrine system, 745
Mueser, 1983, Narcotic Antagonists in Schizophrenia: A Methodological Review, Schizophrenia Bull, 9, 213, 10.1093/schbul/9.2.213
Richelson, 1988, Neuroleptic binding to human brain receptors: relations to clinical effects, Ann NY Acad Sci, 537, 435, 10.1111/j.1749-6632.1988.tb42125.x
Araujo, 1989, Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system, Brain Res, 498, 257, 10.1016/0006-8993(89)91104-9
Bindoni, 1988, Interleukin 2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus, Brain Res, 462, 10, 10.1016/0006-8993(88)90578-1
Smith, 1991, The immune system is a key factor in the etiology of psychosocial disease, Medical Hypoth, 34, 49, 10.1016/0306-9877(91)90064-6
Montgomery, 1990, Identification of prolactin-like proteins synthesized by normal murine lymphocytes, Endocrinol, 127, 2601, 10.1210/endo-127-5-2601
Russell, 1989, New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation, TIPS, 10, 40
Russell, 1984, Prolactin receptors on human lymphocytes and their modulation by cyclosporine, Biochem Biophys Res Comm, 121, 899, 10.1016/0006-291X(84)90762-9
Hiestand, 1986, Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine, 83, 2599
Clevenger, 1990, Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin, 87, 6460
Clevenger, 1990, Interleukin-2 driven nuclear translocation of prolactin in cloned T-lymphocytes, Endocrinol, 127, 3151, 10.1210/endo-127-6-3151
Rubin, 1987, Prolactin and schizophrenia, 803
Van Cauter, 1991, Circadian and sleep-related endocrine rhythms in schizophrenia, Arch Gen Psychiatry, 48, 348, 10.1001/archpsyc.1991.01810280064009
Mukherjee, 1990, Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes, Endocrinol, 126, 88, 10.1210/endo-126-1-88
Perovich, 1989, The behavioral toxicity of bromocriptine in patients with psychiatric illness, J Clin Psychopharmacol, 9, 417, 10.1097/00004714-198912000-00006
Sitland-Marken, 1990, Psychiatric applications of bromocriptine therapy, J Clin Psychiatry, 51, 68
Gattaz, 1989, Acute and subchronic effects of low-dose bromocriptine and haloperidoltreated schizophrenics, Biol Psychiatry, 25, 247, 10.1016/0006-3223(89)90172-8
Levi-Minzi, 1991, Bromocriptine for ‘Negative’ schizophrenia, Compre Psychiatry, 32, 210, 10.1016/0010-440X(91)90041-A
Shenoy, 1983, Bromocriptine in the treatment of galactorrhea caused by haloperidol: a case study, J Clin Psychopharmacol, 3, 187, 10.1097/00004714-198306000-00010
Kellner, 1985, Concurrent use of bromocriptine and fluphenazine (letter), J Clin Psychiatry, 46, 455
Gattaz, 1986, Bromocriptine in the treatment of neuroleptic-resistant schizophrenia, Biol Psychiatry, 21, 519, 10.1016/0006-3223(86)90193-9
Jacob, 1964, Dimethyl sulfoxide (DMSO): A new concept in pharmacotherapy, Curr Therap Res, 6, 134
Jacob, 1965, Dimethyl sulfoxide, its basic pharmacology and usefulness in the therapy of headache, Headache, 5, 78, 10.1111/j.1526-4610.1965.hed0503078.x
Ramirez, 1967, Dimethyl sulfoxide in the treatment of mental patients, Ann NY Acad Sci, 141, 655, 10.1111/j.1749-6632.1967.tb34937.x
Ravid, 1983, Inhibition of phrobol ester-mediated interleukin-2 production by differentiating agents, Cancer Res, 43, 5178
Menninger, 1926, Influenza and schizophrenia. An analysis of post-influenzal ‘dementia precox’, as of 1918, and five years later, Am J Psychiatry, 82, 469, 10.1176/ajp.82.4.469
Goodall, 1932, The exciting cause of certain states of disease, at present classified under ‘schizophrenia’ by psychiatrists, may be infection, J Mental Sci, 78, 746
Delisi, 1987, Viral and immune hypotheses for schizophrenia, 765
Siris, 1988, Postpsychotic depression and negative symptoms. An investigation of syndromal overlap, Am J Psychiatry, 145, 1532, 10.1176/ajp.145.12.1532
Plasky, 1991, Antidepressant usage in schizophrenia, Schizophrenia Bull, 17, 649, 10.1093/schbul/17.4.649
McGlashan, 1992, The positive-negative distinction in schizophrenia, Arch Gen Psychiatry, 49, 63, 10.1001/archpsyc.1992.01820010063008
1989
Solbach, 1991, Lymphocytes play the music but the macrophage calls the tune, Immunol Today, 12, 4, 10.1016/0167-5699(91)90103-Z
Wahl, 1988, Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1 dependent lymphocyte proliferation, J Immunol, 140, 3026, 10.4049/jimmunol.140.9.3026
Pryjma, 1989, Immunoregulatory function of monocytes, 327
Hoover, 1989, Lymphokines as monocyte activators, 151
Niiranen, 1988, Behavioral assessment of patients treated with alpha-interferon, Acta Psychiat Scand, 78, 622, 10.1111/j.1600-0447.1988.tb06395.x
Smith, 1991, The macrophage theory of depression, Medical Hypoth, 35, 298, 10.1016/0306-9877(91)90272-Z
Martinez, 1989, The effects of selected drugs, including chlorpromazine and non-steroidal anti-inflammatory agents, on polyclonal IgG systhesis and interleukin 1 production by human peripheral blood mononuclear cells in vitro, Clin Exp Immunol, 76, 252
Vinogradov, 1991, Negative association between schizophrenia and rheumatoid arthritis, Schizophrenia Bull, 17, 669, 10.1093/schbul/17.4.669
Lotz, 1986, Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis, J Immunol, 136, 3643, 10.4049/jimmunol.136.10.3643
Seeman, 1990, The role of estrogens in schizophrenia gender differences, Schizophrenia Bull, 16, 185, 10.1093/schbul/16.2.185
Flor-Henry, 1990, Influence of gender in schizophrenia as related to other psychopathological syndromes, Schizophrenia Bull, 16, 211, 10.1093/schbul/16.2.211
Hu, 1988, Effect of estradiol on interleukin-1 synthesis by macrophages, Int J Immunopharmac, 10, 247, 10.1016/0192-0561(88)90055-0
Luster, 1984, Estrogen immunosuppression is regulated through estrogenic responses in the thymus, J Immunol, 133, 110, 10.4049/jimmunol.133.1.110
Carsten, 1989, Ostradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits, Immunol, 68, 209
Ahmed, 1985, Effects of short-term administration of sex hormones on normal and autoimmune mice, J Immunol, 134, 204, 10.4049/jimmunol.134.1.204
Guyton, 1991, 889
Orentreich, 1984, Age changes and sex differences in serum dehydroeplandrosterone sulfate concentrations throughout adulthood, J Clin Endocrinol Metab, 59, 551, 10.1210/jcem-59-3-551
Araneo, 1991, Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells, Blood, 78, 688, 10.1182/blood.V78.3.688.688
Daynes, 1990, Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells, Eur J Immunol, 20, 793, 10.1002/eji.1830200413
Talal, 1982, Interleukin-2 deficiency, genes and systemic lupus erythematosus, Arth Rheum, 25, 838, 10.1002/art.1780250725
Guo, 1990, Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis, Endocrinol, 127, 1234, 10.1210/endo-127-3-1234
Meikle, 1991, Reduction of testosterone synthesis after high dose interleukin-2 therapy of metastatic cancer, J Clin Endocrinol Metab, 73, 931f, 10.1210/jcem-73-5-931
Lyketsos, 1983, The sexual adjustment of chronic schizophrenics: a preliminary study, Br J Psychiatry, 143, 376, 10.1192/bjp.143.4.376
Erlenmeyer-Kimling, 1978, Fertility of psychotics: demographics, Ann Rev Schizophrenic Syn, 5, 298
Koran, 1989, Medical evaluation of psychiatric patients, I: Results in a state mental health system, Arch Gen Psychiatry, 46, 733, 10.1001/archpsyc.1989.01810080063007
James, 1988, Intestinal lymphocyte populations and mechanisms of cell-mediated immunity, Immunol Allergy Clin N Amer, 8, 369, 10.1016/S0889-8561(22)00193-X
Soesatyo, 1990, The localization of macrophage subsets and dendritic cells in the gastrointestinal tract of the mouse with special reference to the presence of high endothelial venules, Cell Tissue Res, 259, 587, 10.1007/BF01740787
Zeitz, 1988, Lymphocytes isolated from the intestinal lamina propria of normal nonhuman primates have increased expression of genes associated with T-cell activation, Gastroenterol, 94, 647, 10.1016/0016-5085(88)90235-1
Crabtree, 1989, Serum interleukin-2-receptor in coeliac disease; response to treatment and gluten challenge, Clin Exper Immunol, 77, 345
Miura, 1989, Effect of a traditional Chinese herbal medicine Ren-shen-yang-rong-tang (Japanese name: Ninjin-youel-to) on hematopoietic stem cells in mice, Int J Immunopharmac, 11, 771, 10.1016/0192-0561(89)90131-8
Kawakita, 1990, Induction of interferon after administration of a traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to), Int J Immunopharmac, 12, 515, 10.1016/0192-0561(90)90115-4
Egawa, 1991, Cahi-ling-tang (Japanese name: Sairei-to) as an oral adjuvant, Int J Immunopharm, 13, 1031, 10.1016/0192-0561(91)90058-F
Suzuki, 1989, Immunomodulation by orally administered beta-glucan in mice, Int J Immunopharmac, 11, 761, 10.1016/0192-0561(89)90130-6
Suzuki, 1990, Effect of orally administered beta-glucan on macrophage function in mice, Int J Immunopharmac, 12, 675, 10.1016/0192-0561(90)90105-V
Blomgren, 1989, Oral treatment with RU 41.740 (Biostim) in patients with advanced colorectal cancer; influence on the blood lymphocyte population, Int J Immunopharmac, 11, 71, 10.1016/0192-0561(89)90101-X
Van Daal, 1991, Protection against influenza A virus infection in mice by oral immunization with a polyvalent bacterial lysate, Int J Immunopharmac, 13, 831, 10.1016/0192-0561(91)90034-5
Suzuki, 1991, Oral administration of a streptococcal agent OK-432 activates peritoneal macrophages in mice, Int J Immunopharmac, 13, 147, 10.1016/0192-0561(91)90092-L
Ngwenya, 1991, Activation of peritoneal macrophages by orally administered ether analogues of lysophospholipids, 197, 91
Shannon, 1922, Neuropathic manifestations in infants and children as a result of anaphylactic reaction to foods contained in their dietary, Am J Dis Child, 24, 89
Egger, 1983, Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment, Lancet, 2, 865, 10.1016/S0140-6736(83)90866-8
Egger, 1985, Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome, Lancet, 1, 540, 10.1016/S0140-6736(85)91206-1